TRENTIN, LUCIANO

Nome completo

TRENTIN, LUCIANO

Afferenza

Universita' degli Studi di MILANO

Mostra records

Risultati 1 - 3 di 3 (tempo di esecuzione: 0.004 secondi).

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab

2020 M. Gentile, E.A. Martino, A. Visentin, M. Coscia, G. Reda, P. Sportoletti, F.R. Mauro, L. Laurenti, M. Varettoni, R. Murru, A. Chiarenza, E. Vigna, F. Mendicino, E. Lucia, S. Bossio, A.G. Recchia, R. Moia, D. Pietrasanta, G. Loseto, U. Consoli, I. Scortechini, F.M. Rossi, A. Zucchetto, H. Al-Janazreh, C. Vitale, G. Tripepi, G. D'Arrigo, I. Angeletti, R. Bomben, A. Neri, G. Cutrona, G. Fronza, F. Di Raimondo, G. Gaidano, A. Cuneo, R. Foa, M. Ferrarini, L. Trentin, V. Gattei, F. Morabito

P66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes

2018 L. Patrussi, N. Capitani, F. Cattaneo, N. Manganaro, A. Gamberucci, F. Frezzato, V. Martini, A. Visentin, P.G. Pelicci, M.M. D'Elios, L. Trentin, G. Semenzato, C.T. Baldari

The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes

2004 R. Zambello, A. Cabrelle, L. Trentin, C. Agostini, G. Semenzato, A. Viola

Titolo	Data di pubblicazione	Autori	Tipo	Abstract
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab	2020	Gentile M.Martino E. A.Visentin A.Coscia M.Reda G.Sportoletti P.Mauro F. R.Laurenti L.Varettoni M.Murru R.Chiarenza A.Vigna E.Mendicino F.Lucia E.Bossio S.Recchia A. G.Moia R.Pietrasanta D.Loseto G.Consoli U.Scortechini I.Rossi F. M.Zucchetto A.Al-Janazreh H.Vitale C.Tripepi G.D'Arrigo G.Angeletti I.Bomben R.Neri A.Cutrona G.Fronza G.Di Raimondo F.Gaidano G.Cuneo A.Foa R.Ferrarini M.Trentin L.Gattei V.Morabito F. + -	Article (author)	-
P66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes	2018	Patrussi L.Capitani N.Cattaneo F.Manganaro N.Gamberucci A.Frezzato F.Martini V.VISENTIN, AURORA BIANCA MARIAPelicci P. G.D'Elios M. M.Trentin L.Semenzato G.Baldari C. T. + -	Article (author)	-
The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes	2004	R. ZambelloA. CabrelleL. TrentinC. AgostiniG. SemenzatoA. Viola + -	Article (author)	-

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

TRENTIN, LUCIANO

Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab

P66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes

The raft marker GM1 identifies functional subsets of granular lymphocytes in patients with CD3+ lymphoproliferative disease of granular lymphocytes